SGBI — Sangui Biotech International Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual balance sheet for Sangui Biotech International, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2018 June 30th | 2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 0.021 | 0.027 | 0.015 | 0.03 | 0.03 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.058 | 0.042 | 0.02 | 0.025 | 0.025 |
| Prepaid Expenses | |||||
| Total Current Assets | 0.102 | 0.079 | 0.049 | 0.067 | 0.068 |
| Net Property, Plant And Equipment | 0 | 0 | 0.077 | 0.067 | 0.063 |
| Total Assets | 0.102 | 0.079 | 0.125 | 0.134 | 0.131 |
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.453 | 0.671 | 0.791 | 0.955 | 0.936 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | -0.169 | 0.03 | 0.208 | 0.358 | 0.37 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 0.271 | 0.049 | -0.083 | -0.224 | -0.239 |
| Total Liabilities & Shareholders' Equity | 0.102 | 0.079 | 0.125 | 0.134 | 0.131 |
| Total Common Shares Outstanding |